Plain-English translation of NCT07288021 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether EMLA, a topical numbing cream, can reduce pain when a catheter (a small balloon) is placed in the vagina to start labor. Researchers will compare pain levels and satisfaction between people who receive the numbing cream and those who receive a placebo (a cream with no active ingredient). The study includes both people who have given birth before and those who have not.
Labor induction with a balloon catheter can be uncomfortable or painful for pregnant people. Researchers want to know if this medication can safely reduce that pain and improve the overall experience without harming the pregnancy or baby.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the numbing cream or a placebo before your catheter is inserted for labor induction. You won't know which one you're getting. The research team will ask you about your pain level and satisfaction with the procedure using standard pain scales. The study takes place during your scheduled labor induction visit, so there are no additional appointments needed.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Israel